Status:

COMPLETED

Dose Reduction in Thoracic CT

Lead Sponsor:

University Health Network, Toronto

Conditions:

Lymphoma

Eligibility:

All Genders

16+ years

Phase:

PHASE1

Brief Summary

Hypothesis: Does a 50% reduction in radiation in dose significantly affect the diagnostic quality of chest CT

Detailed Description

Patients with Lymphoma are recruited and have a follow up CT performed at 50% of the standard exposure parameters. The studies are compared for image quality with a recent (\<3 months) thoracic CT per...

Eligibility Criteria

Inclusion

  • Patients with Lymphoma

Exclusion

  • No recent (\<3 months) thoracic CT

Key Trial Info

Start Date :

January 1 2004

Trial Type :

INTERVENTIONAL

End Date :

August 1 2005

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00188461

Start Date

January 1 2004

End Date

August 1 2005

Last Update

April 23 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Toronto General Hospital

Toronto, Ontario, Canada